Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma

Hepatology

Volumn 53, Issue 4, 2011, Pages 1237-1245

  Ohishi, Waka ^a   Fujiwara, Saeko ^a   Cologne, John B ^b   Suzuki, Gen ^c   Akahoshi, Masazumi ^b   Nishi, Nobuo ^d   Tsuge, Masataka ^e   Chayama, Kazuaki ^e  

^a Department of Clinical Studies ^*  (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

AGED; ALCOHOL CONSUMPTION; ARTICLE; ATOMIC BOMB SURVIVOR; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SMOKING HABIT;

AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WEAPONS; RISK FACTORS; SMOKING;

EID: 79953738068     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24207     Document Type: Article

References (47)

1. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomar 2008; 17: 846-854.
2. Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 2007; 37: S95-S100.
3. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B, non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008; 43: 967-974.
4. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. HEPATOLOGY 2002; 36: 1349-1354.
5. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119.
6. Yoshiike N, Lwin H. Epidemiological aspects of obesity and NASH/NAFLD in Japan. Hepatol Res 2005; 33: 77-82.
7. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002; 323: 140-145.
8. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
9. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-1877.
10. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127: S97-103.
11. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218-224.
12. Saunders D, Seidel D, Allison M, Lyratzopoulos G. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther 2010; 31: 1051-63.
13. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994; 137: S17-67.
14. Cologne JB, Tokuoka S, Beebe GW, Fukuhara T, Mabuchi K. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat Res 1999; 152: 364-373.
15. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160: 381-407.
16. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 1-64.
17. Kato H, Mayumi M, Nishioka K, Hamilton HB. The relationship of hepatitis B surface antigen and antibody to atomic-bomb radiation in the Adult Health Study sample, 1975-1977. Am J Epidemiol 1983; 117: 610-620.
18. Neriishi K, Akiba S, Amano T, Ogino T, Kodama K. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic-bomb survivors. Radiat Res 1995; 144: 215-221.
19. Fujiwara S, Sharp GB, Cologne JB, Kusumi S, Akahoshi M, Kodama K, et al. Prevalence of hepatitis B virus infection among atomic bomb survivors. Radiat Res 2003; 159: 780-786.
20. Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiat Res 2000; 154: 12-19.
21. Sharp GB, Mizuno T, Cologne JB, Fukuhara T, Fujiwara S, Tokuoka S, et al. Hepatocellular carcinoma among atomic bomb survivors: significant interaction of radiation with hepatitis C virus infections. Int J Cancer 2003; 103: 531-537.
22. Gilbert ES, Koshurnikova NA, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, et al. Liver cancers in Mayak workers. Radiat Res 2000; 154: 246-252.
23. Tokarskaya ZB, Zhuntova GV, Scott BR, Khokhryakov VF, Belyaeva ZD, Vasilenko EK, et al. Influence of alpha and gamma radiations and non-radiation risk factors on the incidence of malignant liver tumors among Mayak PA workers. Health Phys 2006; 91: 296-310.
24. Sokolnikov ME, Gilbert ES, Preston DL, Ron E, Shilnikova NS, Khokhryakov VV, et al. Lung, liver and bone cancer mortality in Mayak workers. Int J Cancer 2008; 123: 905-911.
25. Tanaka IB 3rd, Tanaka S, Ichinohe K, Matsushita S, Matsumoto T, Otsu H, et al. Cause of death and neoplasia in mice continuously exposed to very low dose rates of gamma rays. Radiat Res 2007; 167: 417-437.26.
26. Fukuhara T, Sharp GB, Mizuno T, Itakura H, Yamamoto M, Tokunaga M, et al. Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses. J Radiat Res 2001; 42: 117-130.
27. Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, Nakachi K. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol 2004; 33: 485-492.
28. Ohishi W, Fujiwara S, Suzuki G, Kishi T, Sora M, Matsuura S, et al. Feasibility of freeze-dried sera for serological and molecular biological detection of hepatitis B and C viruses. J Clin Microbiol 2006; 44: 4593-4595.
29. Ohishi W, Fujiwara S, Suzuki G, Chayama K. Validation of the use of freeze-dried sera for the diagnosis of hepatitis B and C virus infections in a longitudinal study cohort. In: Mohan RM, ed. Research Advances in Microbiology 7. Kerala, India: Global Research Network; 2007: 1-9.
30. Young RW, Kerr GD, editors. Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki, Dosimetry System 2002, Report of the Joint US-Japan Working Group. Hiroshima, Japan: Radiation Effects Research Foundation; 2005.
31. Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N, et al. Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case-control study in Japan. Int J Cancer 2005; 115: 290-295.
32. The World Health Organization Western Pacific Region; The International Association for the Study; The International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia: Health Communications Australia Pty Limited; 2000.
33. Langholz B, Borgan Ø. Counter-matching: a stratified nested case-control sampling method. Biometrika 1985; 82: 69-79.
34. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume 1-The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980.
35. Cologne JB, Shibata Y. Optimal case-control matching in practice. Epidemiology 1995; 6: 271-275.
36. Cologne J, Langholz B. Selecting controls for assessing interaction in nested case-control studies. J Epidemiol 2003; 13: 193-202.
37. Cologne JB, Tokuoka S, Beebe GW, Fukuhara T, Mabuchi K. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat Res 1999; 152: 364-373.
38. Belsky JL, King RA, Ishimaru T, Hamilton HB, Nakahara Y. Hepatitis-associated antigen in atomic bomb survivors and nonexposed control subjects: seroepidemiologic survey in a fixed cohort. J Infect Dis 1973; 128: 1-6.
39. IARC. IARC Monographs on the evaluation of the carcinogenic risks to humans. Volume 83: tobacco smoke and involuntary smoking. Lyon, France: IARC; 2004.
40. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127: S72-8.
41. Andersson M. Long-term effects of internally deposited alpha-particle emitting radionuclides. Epidemiological, pathological and molecular-biological studies of Danish Thorotrast-administered patients and their offspring. Dan Med Bull 1997; 44: 169-190.
42. Baxter PJ, Langlands AO, Anthony PP, Macsween RN, Scheuer PJ. Angiosarcoma of the liver: a marker tumour for the late effects of Thorotrast in Great Britain. Br J Cancer 1980; 41: 446-453.
43. Sharp GB. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data. J Radiat Res 2002; 43: 371-380.
44. Iwamoto KS, Mizuno T, Tokuoka S, Mabuchi K, Seyama T. Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors. J Natl Cancer Inst 1998; 90: 1167-1168.
45. Nakamura S, Tanaka IB 3rd, Tanaka S, Nakaya K, Sakata N, Oghiso Y. Adiposity in female B6C3F1 mice continuously irradiated with low-dose-rate gamma rays. Radiat Res 2010; 173: 333-341.
46. Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol 2004; 41: 685-690.
47. Akahoshi M, Amasaki Y, Soda M, Hida A, Imaizumi M, Nakashima E, et al. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res 2003; 26: 965-970.